Windtree Therapeutics, Inc. (NASDAQ:WINT) to Post Q4 2023 Earnings of ($0.94) Per Share, HC Wainwright Forecasts
Windtree Therapeutics, Inc. (NASDAQ:WINT – Free Report) – Research analysts at HC Wainwright issued their Q4 2023 earnings estimates for shares of Windtree Therapeutics in a report released on Wednesday, January 3rd. HC Wainwright analyst V. Bernardino anticipates that the company will post earnings per share of ($0.94) for the quarter. HC Wainwright has a […]
More Stories
America Votes: What to Expect
By Lawrence Wilson Democrats appear poised to win control of the House and possibly the Senate on Nov. 3 as...
One Canadian Confirmed Among 69 Victims of Fatal Spanish Train Crash
By Jennifer Cowen Global Affairs has confirmed one Canadian was killed in last week’s high-speed rail collision in Spain. Sixty-nine...
All of Us Are Dead Season 2: Recent Updates and Cast Members
After letting fans wait for almost 4 years, All of Us Are Dead is getting ready for the continuation of...
US Took Enforcement Action Against 2.2 Million Illegal Immigrants, Officials Say
By Jack Phillips U.S. immigration officials say that the second Trump administration has moved to terminate or revoke the status...
Why Did Emily Osment Request an Intimate Coordinator for Young Sheldon?
Emily Osment’s recently commented on her behind-the-scenes experience with co-star Montana Jordan during Young Sheldon’s shooting. It is making headlines...
GM Agrees to $220 Million Settlement Over Selling Driver Data
By Naveen Athrappully General Motors (GM) has agreed to a $220 million settlement with a coalition of 36 attorneys general...